- Service Name
Vaxcyte
- Industry
Healthcare, Biotechnology, Vaccines, Infectious Diseases
- Main Value Proposition
Vaxcyte offers innovative vaccines that aim to eliminate bacterial infections, thereby protecting vulnerable populations globally.
- Description
Vaxcyte is a clinical-stage vaccine innovation company dedicated to developing high-fidelity vaccines that protect against bacterial infections. Their focus is on creating broad-spectrum vaccines to combat diseases such as invasive pneumococcal disease and Group A Strep.
- Key Features
24-valent PCV candidate (VAX-24) with FDA Breakthrough Therapy designation; Advanced XpressCF™ cell-free protein synthesis platform; Broad-spectrum coverage against invasive pneumococcal disease; Pipeline of vaccines targeting multiple bacterial infections
- Use Cases
Preventing invasive pneumococcal disease in adults and children; Addressing antibiotic resistance through innovative vaccine solutions; Providing vaccines for high-risk populations, including infants
- Competitive advantages
Broadest-spectrum pneumococcal conjugate vaccine available in U.S. clinics; FDA Breakthrough Therapy designation for rapid development; Innovative cell-free protein synthesis technology for vaccine production
- Strengths
Vaxcyte's strengths lie in its cutting-edge technology, a strong pipeline of vaccine candidates, and a commitment to addressing significant public health challenges posed by bacterial infections.
- Positioning
Vaxcyte positions itself as a leader in vaccine innovation, focusing on high-fidelity solutions to combat bacterial diseases that are often overlooked by traditional vaccine approaches.
- Audience
The primary target users include healthcare providers, public health organizations, and families with children at risk of bacterial infections.
- CTA
See Our Mission, Learn About Us, Explore Approach, View Pipeline, Visit Careers
- Tags
Vaccines
Infectious Diseases
Bacterial Infections
Public Health
- Tagline
Vaccine Innovation. Beyond Convention.
- Tone of Voice
Innovative, authoritative, compassionate
- Differentiation
Vaxcyte's unique approach combines advanced synthetic techniques with a focus on high-fidelity vaccine development, setting it apart from conventional vaccine manufacturers.
- Brand Positioning
Vaxcyte's brand identity emphasizes innovation, safety, and a commitment to global health, aiming to inspire trust and confidence in its vaccine solutions.
- Founded
2013-12-01
- Founders
Ash Khanna
Grant E. Pickering
Jeff Fairman